Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies
The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The authors assessed the association of smoking with dementia and cognitive decline in a meta-analysis of 19 prospective studies with at least 12 months of follow-up. Studies included a total of 26,374 participants followed for dementia for 2-30 years and 17,023 participants followed up for 2-7 years to assess cognitive decline. Mean study age was 74 years. Current smokers at baseline, relative to never smokers, had risks of 1.79 (95% confidence interval (CI): 1.43, 2.23) for incident Alzheimer's disease, 1.78 (95% CI: 1.28, 2.47) for incident vascular dementia, and 1.27 (95% CI: 1.02, 1.60) for any dementia. Compared with those who never smoked, current smokers at baseline also showed greater yearly declines in Mini-Mental State Examination scores over the follow-up period (effect size (beta)=-0.13, 95% CI: -0.18, -0.08). Compared with former smokers, current smokers at baseline showed an increased risk of Alzheimer's disease (relative risk=1.70, 95% CI: 1.25, 2.31) and an increased decline in cognitive abilities (effect size (beta)=-0.07, 95% CI: -0.11, -0.03), but the groups were not different regarding risk of vascular dementia or any dementia. The authors concluded that elderly smokers have increased risks of dementia and cognitive decline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although risk may be specific for certain cognitive domains,325”
In the citing paper
“Smoking has been implicated in the risk of cognitive decline68,69 and dementia70 through atherosclerosis, inflammation, and oxidative stress pathways.68,69”
From Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association (2017) · cites this paper as [68]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Cochrane Handbook for Systematic Reviews of Interventions
Higgins, J. P. T., Green, S., & Ben Van Den, A. (2020) · International Coaching Psychology Review · doi:10.53841/bpsicpr.2020.15.2.123 · Cited by 5,670
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
Spitzer, R. L., & Williams, J. (1987) · Cited by 1,823
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 1,495
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · cited 2×
“CADDTC * 77.4 (4.0) 100 10.8 (3.1) Lindsay, 2002 ( 9 )”
InfluentialCardiovascular risk factors and cognitive decline in middle-aged adults
Knopman, D., Boland, L. L., Mosley, T., Howard, G., Liao, D., Szklo, M., McGovern, P., & Folsom, A. R. (2001) · Neurology · doi:10.1212/wnl.56.1.42 · Cited by 883
Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., et al. (1995) · Neurology · doi:10.1212/wnl.45.6.1161 · Cited by 829
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790
Rates and risk factors for dementia and Alzheimer’s disease: Results from EURODEM pooled analyses
Launer, L. J., Andersen, K., Dewey, M. E., Letenneur, L., Ott, A., Amaducci, L. A., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh-Sorensen, P., et al. (1999) · Neurology · doi:10.1212/wnl.52.1.78 · Cited by 758 · cited 7×
“Launer, 1999 ( 14 )§ 40.33 1.46 0.90, 2.37”
BackgroundInfluentialOtt, A., Slooter, A., Hofman, A., van Harskamp, F., Witteman, J., Van Broeckhoven, C., van Duijn, C., & Breteler, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07541-7 · Cited by 535
Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2003) · Archives of Neurology · doi:10.1001/archneur.60.2.203 · Cited by 414 · cited 2×
“Result of contact with authors: 1 publication of the WHICAP study ( 8 ) was replaced by a later publication (7) as recommended by the author 9 publications were excluded because of lack of relevant data: authors were either uncontactable or unable to provide data 1 previously excluded publication (26) was reselected f…”
BackgroundMethodFree testosterone and risk for Alzheimer disease in older men
Moffat, S. D., Zonderman, A. B., Metter, E. J., Kawas, C., Blackman, M. R., Harman, S. M., & Resnick, S. M. (2004) · Neurology · doi:10.1212/wnl.62.2.188 · Cited by 383
Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E ε4 status
Graves, A. B., Bowen, J. D., Rajaram, L., McCormick, W. C., McCurry, S. M., Schellenberg, G. D., & Larson, E. B. (1999) · Neurology · doi:10.1212/wnl.53.7.1480 · Cited by 300
Fontbonne, A., Berr, C., Ducimetière, P., & Alpérovitch, A. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.366 · Cited by 297
Effect of Smoking Reduction on Lung Cancer Risk
Godtfredsen, N. S. (2005) · JAMA · doi:10.1001/jama.294.12.1505 · Cited by 275
Mixed Dementia: Epidemiology, Diagnosis, and Treatment
Zekry, D., Hauw, J., & Gold, G. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50367.x · Cited by 243 · cited 1×
“Lewy bodies (53), frontotemporal dementia (54), Pick’s disease, alcohol-related dementia, and mixed ( 55 ) and other dementias.”
BackgroundBakhru, A., & Erlinger, T. P. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020160 · Cited by 235
Laurin, D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh124 · Cited by 231 · cited 17×
“Broe, 1998 (12)y 5.81 1.03 0.45, 2.37 Laurin, 2004 ( 15 )z 23.03 1.03 0.68, 1.56”
BackgroundResultInfluentialMid-life smoking and late-life dementia: the Honolulu-Asia Aging Study
Tyas, S. L., White, L. R., Petrovitch, H., Webster Ross, G., Foley, D. J., Heimovitz, H. K., & Launer, L. J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00156-2 · Cited by 226
Nicotine Inhibits Amyloid Formation by the β-Peptide
Salomon, A. R., Marcinowski, K. J., Friedland, R. P., & Zagorski, M. G. (1996) · Biochemistry · doi:10.1021/bi9617264 · Cited by 220
Cigarette Smoking and Cognitive Decline in Midlife: Evidence From a Prospective Birth Cohort Study
Richards, M., Jarvis, M. J., Thompson, N., & Wadsworth, M. E. J. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.6.994 · Cited by 204
The influence of smoking on the risk of Alzheimer’s disease
Merchant, C., Tang, M.-X., Albert, S., Manly, J., Stern, Y., & Mayeux, R. (1999) · Neurology · doi:10.1212/wnl.52.7.1408 · Cited by 197
Effect of smoking on global cognitive function in nondemented elderly
Ott, A., Andersen, K., Dewey, M. E., Letenneur, L., Brayne, C., Copeland, J. R. M., Dartigues, J.-F., Kragh–Sorensen, P., Lobo, A., Martinez–Lage, J. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000115110.35610.80 · Cited by 183
Almeida, O. P., Hulse, G. K., Lawrence, D., & Flicker, L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00016.x · Cited by 175
Weisskopf, M. G., Wright, R. O., Schwartz, J., Spiro, A., Sparrow, D., Aro, A., & Hu, H. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh333 · Cited by 174
Broe, G. A., Creasey, H., Jorm, A. F., Bennett, H. P., Casey, B., Waite, L. M., Grayson, D. A., & Cullen, J. (1998) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.1998.tb01449.x · Cited by 169
Smoking, Drinking, and Thinking: The Zutphen Elderly Study: The Zutphen Elderly Study
Launer, L. J., Feskens, E. J. M., Kalmijn, S., & Kromhout, D. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008732 · Cited by 163
Cervilla, J. A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.5.622 · Cited by 161
Omega-3 fatty acids and risk of cognitive impairment and dementia
Laurin, D., Verreault, R., Lindsay, J., Dewailly, É., & Holub, B. J. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5407 · Cited by 145
Nicotine enhances delayed matching-to-sample performance by primates
Elrod, K., Buccafusco, J. J., & Jackson, W. J. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90318-9 · Cited by 142
Cohort Study of Vitamin C Intake and Cognitive Impairment
Paleologos, M., Cumming, R. G., & Lazarus, R. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009559 · Cited by 137
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
Beeri, M. S., Rapp, M., Silverman, J. M., Schmeidler, J., Grossman, H. T., Fallon, J. T., Purohit, D. P., Perl, D. P., Siddiqui, A., Lesser, G., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000210447.19748.0b · Cited by 129
Hebert, L. E., Scherr, P. A., Beckett, L. A., Albert, M. S., Rosner, B., Talor, J. O., & Evans, D. A. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116749 · Cited by 128
Meta-Analysis of Nonsteroidal Antiinflammatory Drug Use and Risk of Dementia
de Craen, A. J. M. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi029 · Cited by 123
A 2‐year follow‐up study of cigarette smoking and risk of dementia
Juan, D., Zhou, D. H. D., Li, J., Wang, J. Y. J., Gao, C., & Chen, M. (2004) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00779.x · Cited by 118
Dufouil, C., Tzourio, C., Brayne, C., Berr, C., Amouyel, P., & Alpérovitch, A. (2000) · Epidemiology · doi:10.1097/00001648-200005000-00009 · Cited by 117
Wang, H.-X., Fratiglioni, L., Frisoni, G. B., Viitanen, M., & Winblad, B. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009864 · Cited by 110
Piguet, O., Grayson, D. A., Creasey, H., Bennett, H. P., Brooks, W. S., Waite, L. M., & Broe, G. A. (2003) · Neuroepidemiology · doi:10.1159/000069886 · Cited by 100
Relationship of Race/Ethnicity and Blood Pressure to Change in Cognitive Function
Bohannon, A. D., Fillenbaum, G. G., Pieper, C. F., Hanlon, J. T., & Blazer, D. G. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50104.x · Cited by 87
NILSSON, P. M., NILSSON, J. ‐., & BERGLUND, G. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01671.x · Cited by 85
Bone Loss Predicts Subsequent Cognitive Decline in Older Women: The Study of Osteoporotic Fractures
Lui, L., Stone, K., Cauley, J. A., Hillier, T., & Yaffe, K. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1601-5215.2002.51007.x · Cited by 85
Kivohara, Y., Fuiishima, M., Yoshitake, T., Kato, I., Iwamoto, H., & Nakayama, K. I. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)80315-0 · Cited by 79
Vitamin E biokinetics, oxidative stress and cigarette smoking
Bruno, R. S., & Traber, M. G. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.003 · Cited by 74
Serrano, M., Madoz, E., Ezpeleta, I., Julián, B. S., Amézqueta, C., Marco, J. A. P., & de Irala, J. (2003) · Revista Española de Cardiología · doi:10.1016/s0300-8932(03)76898-5 · Cited by 52
Smoking and Cognitive Impairment: A Population‐Based Study
Ford, A. B., Mefrouche, Z., Friedland, R. P., & Debanne, S. M. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01858.x · Cited by 50
Smoking and drinking cessation and risk of esophageal cancer (Spain)
Castellsagué, X., Muñóz, N., Stéfani, E. D., Victora, C. G., Quintana, M. J., Castelletto, R. H., & Rolón, P. A. (2000) · Cancer Causes & Control · doi:10.1023/a:1008984922453 · Cited by 40
Transitions in cognitive status among the aged in Japan
Liang, J., Borawski, E. A., Liu, X., & Sugisawa, H. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00381-9 · Cited by 38
The influence of smoking on the risk of Alzheimer's disease
Riggs, J. E., & Merchant, C. (2000) · Neurology · doi:10.1212/wnl.54.3.777-a · Cited by 37
Lipoprotein(a) and Cognitive Performances in an Elderly White Population
Sarti, C., Pantoni, L., Pracucci, G., Carlo, A. D., Vanni, P., & Inzitari, D. (2001) · Stroke · doi:10.1161/01.str.32.7.1678 · Cited by 25
Smoking and Cognitive Performance in the Community Elderly: A Longitudinal Study
Chen, W.-T., Wang, P.-N., Wang, S.-J., Fuh, J.-L., Lin, K.-N., & Liu, H.-C. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988702250510 · Cited by 24
Brayne, C. (2000) · BMJ · doi:10.1136/bmj.320.7242.1087 · Cited by 24
Depression predicts cognitive decline in Hong Kong Chinese older adults
Chi, I., & Chou, K. (2000) · Aging & Mental Health · doi:10.1080/13607860050008673 · Cited by 21
Whittington, J. E., & Huppert, F. A. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199709/10)12:5<467::aid-hup908>3.0.co;2-x · Cited by 18
Whittington, J. E., & Huppert, F. A. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199709/10)12:5<497::aid-hup912>3.0.co;2-a · Cited by 14
Smoking and Cognitive Performance in the Community Elderly: A Longitudinal Study
Chen, W., Wang, P., Wang, S., et al. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703016001005 · Cited by 3
Cited by
Nichols, E., Steinmetz, J. D., Vollset, S. E., Fukutaki, K., Chalek, J., Abd-Allah, F., Abdoli, A., Abualhasan, A., Abu-Gharbieh, E., Akram, T. T., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00249-8 · Cited by 5,575
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Metadata
- Authors
- Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R.
- Affiliations
- Australian National University (AU)
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-14
- Volume
- 166
- Issue
- 4
- Pages
- 367-378
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2115620754
- Cited by
- 921
- References
- 61
- Citations by year
- 2026: 38 · 2025: 47 · 2024: 53 · 2023: 42 · 2022: 58 · 2021: 48 · 2020: 67 · 2019: 56 · 2018: 59 · 2017: 50 · 2016: 50 · 2015: 59 · 2014: 55 · 2013: 42 · 2012: 58
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- National Health and Medical Research Council
- National Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- smoking, dementia, cognitive decline, Alzheimer's disease, vascular dementia, Mini-Mental State Examination, former smokers, older adults, risk factors
- MeSH terms
- Aged, Cognition Disorders, Dementia, Female, Follow-Up Studies, Humans, Male, Prospective Studies, Risk Factors, Smoking, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.